Incretin-Based Therapies and Cancer: What’s New?

Incretin-Based Therapies and Cancer: What’s New?

Growing interest in incretin-based therapies for diabetes mellitus has led to an increased evaluation of their potential effects on cancer development. This review aims to synthesize recent evidence regarding the relationship between incretin-based therapies and cancer risk. We conducted a comprehen...

Full description

Saved in:
Bibliographic Details
Main Authors: Sanja Medenica, Jelena Bogdanovic, Jelena Vekic, Tanja Vojinovic, Ivana Babic, Ljiljana Bogdanović, Viviana Maggio, Mohamed El Tanani, Manfredi Rizzo
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Medicina
Subjects:
DPP-4 inhibitors
GLP-1/GIP agonists
diabetes mellitus
obesity
cancer
Online Access:https://www.mdpi.com/1648-9144/61/4/678
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1648-9144/61/4/678

Similar Items